Task: Answer the multiple-choice question.
Question: Which drug exhibits a 3.425% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a O=c1cc(-c2ccccc2)cc(-c2ccccc2)n1CCO
b Cc1cc(C)c2nc(-c3ccccn3)cc(C(=O)n3cccn3)c2c1
c CCOC(=O)c1oc2ccc(CNCCO)c(Cl)c2c1C
Answer: c. CCOC(=O)c1oc2ccc(CNCCO)c(Cl)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)c1oc2ccc(CNCCO)c(Cl)c2c1C
CCOC(=O)c1oc2ccc(CNCCO)c(Cl)c2c1C
ethyl 4-chloro-5-[(2-hydroxyethylamino)methyl]-3-methyl-1-benzofuran-2-carboxylate